Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cullinan Therapeutics, Inc.

CGEM Clue Score48
United States Fiscal year ends December CIK 0001789972 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Michaelson
8 Sep 2026
Chief Scientific Officer
Sold after exercise
8,000
$21.57
$172.56K
Jennifer Michaelson
13 Aug 2026
Chief Scientific Officer
Sold after exercise
30,000
$20.26
$607.80K
Jennifer Michaelson
6 Jul 2026
Chief Scientific Officer
Sold after exercise
8,000
$17.82
$142.56K
Jennifer Michaelson
5 May 2026
Chief Scientific Officer
Sold after exercise
200
$15.58
$3.12K
Jennifer Michaelson
5 May 2026
Chief Scientific Officer
Sold after exercise
7,800
$14.60
$113.88K
Jennifer Michaelson
5 Mar 2026
Chief Scientific Officer
Sold after exercise
8,000
$15.68
$125.44K
Jennifer Michaelson
20 Feb 2026
Chief Scientific Officer
Sold after exercise
8,000
$14.30
$114.40K
Jennifer Michaelson
20 Feb 2026
Chief Scientific Officer
Sold after exercise
3,742
$13.62
$50.97K

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 8
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 184,288
History held since 11 Jan 2021